Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1999
09/28/1999US5959075 Testis-specific insulin homolog polypeptides
09/28/1999US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same
09/28/1999US5958941 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs
09/28/1999US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
09/28/1999US5958909 Insulinotropic hormones and uses thereof
09/28/1999US5958907 Pharmaceutical compositions and uses of inorganic pyrophosphates
09/28/1999US5958902 Method and composition for treating sleep apnea
09/28/1999US5958893 Dna molecule
09/28/1999US5958892 2-methoxyestradiol-induced apoptosis in cancer cells
09/28/1999US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation
09/28/1999US5958887 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections
09/28/1999US5958886 Carnitine-containing peptides and a method for using the same
09/28/1999US5958885 Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood
09/28/1999US5958884 Compositions and methods for treating erectile dysfunction
09/28/1999US5958883 For preventing or treating alzheimer's disease, comprising administering to a subject in need thereof a peptide within an amyloid protein associated with alzheimer's disease
09/28/1999US5958882 Compounds that inhibit T cell proliferation and methods using the same
09/28/1999US5958881 Comprising peptide having amino acid sequence of vasoactive intestinal peptide; for inducing temporary substantial paralysis an area of interest in patients undergoing endoscopy or other medical procedure; side effect reduction
09/28/1999US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
09/28/1999US5958879 Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
09/28/1999US5958877 Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide
09/28/1999US5958876 Cyclosporin-containing pharmaceutical compositions
09/28/1999US5958874 Recombinant fibronectin-based extracellular matrix for wound healing
09/28/1999US5958873 Oral formulation for treatment of bacteria-induced diseases of the colon
09/28/1999US5958872 Active survival domains of IGF-IR and methods of use
09/28/1999US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression
09/28/1999US5958771 Oligonucleotide from 8 to 30 nucleotides in length; for diagnosis and therapy; antitumor/antiinflammatory agents
09/28/1999US5958770 Glycoalkaloids
09/28/1999US5958769 Compositions and methods for mediating cell cycle progression
09/28/1999US5958768 Compositions for the treatment and diagnosis of infections of rev-binding primate lentiviruses are provided. the primate lentiviruses, including human immunodeficiency virus (hiv) type 1 (hiv-1), and type 2 (hiv-2) and siv are genetically,
09/28/1999US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein
09/28/1999US5958753 Nucleic acid sequences encoding Bau, a Bin1 interacting protein, and vectors and host cells containing same
09/28/1999US5958750 Purified polynucleotide encoding a novel human hyaluronidase polypeptide; expression vectors and transformed host cells for the production of the polypeptide
09/28/1999US5958746 Electron transport proteins
09/28/1999US5958737 Single-chain β subunit dimers of the glycoprotein hormones and recombinant materials related thereto
09/28/1999US5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
09/28/1999US5958735 Polynucleotides encoding urogenital sinus derived growth inhibitory factor and vectors
09/28/1999US5958732 Anticoagulants in snake venom
09/28/1999US5958731 Cell junction PDZ protein
09/28/1999US5958729 7-transmembrane receptor (a g-protein coupled receptor) identified as a human g-protein pituitary adenylate cyclase activating polypeptide (pacap)-like receptor for amnesiac like neuropeptides, referred to as ?hcegh45?; alzheimer's
09/28/1999US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases
09/28/1999US5958725 Human DP1 homolog
09/28/1999US5958723 DNA encoding prostaglandin receptor DP
09/28/1999US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/28/1999US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response
09/28/1999US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder
09/28/1999US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and
09/28/1999US5958709 Processes for identifying compounds that bind to the human Y4 receptor
09/28/1999US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
09/28/1999US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer
09/28/1999US5958697 Isolated nucleic acids encoding CYP7 promoter-binding factors
09/28/1999US5958690 Human TSC--22 Homolog
09/28/1999US5958685 Sequence encoding thr replaced by sequence encoding ala
09/28/1999US5958683 Screening method using the RZR receptor family
09/28/1999US5958682 Virus-directed enzyme prodrug therapy for treating tumor cells consisting of a viral vector encoding bacterial nitroreductase capable of converting a prodrug into a cytotoxic drug operably linked to a promoter; and the prodrug
09/28/1999US5958678 A single-stranded nucleic acid molecule which encodes an amino acid sequence comprising at least a portion of a t4 glycoprotein is provided.
09/28/1999US5958671 Methods and compositions for regulating T cell subsets by modulating transcription factor activity
09/28/1999US5958457 Compositions for the delivery of antigens
09/28/1999US5958442 Oncostatin M for treating inflammation
09/28/1999US5958441 Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith
09/28/1999US5958428 Synthetic compounds and compositions with enhanced cell binding
09/28/1999US5958425 Viral vaccines
09/28/1999US5958424 Recombinant chicken anemia virus particle
09/28/1999US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines
09/28/1999US5958416 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
09/28/1999US5958415 Protein allergen of Derf II and composition
09/28/1999US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression
09/28/1999US5958411 Methods of inhibiting ECM accumulation in the CNS by inhibition of TGF-β
09/28/1999US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis
09/28/1999US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance
09/28/1999US5958407 Ileus treatment method
09/28/1999US5958406 Acne treatment with multifunctional enzyme
09/28/1999US5958405 Human protein tyrosine kinase
09/28/1999US5958404 Grafting cells for treatment of disease and diabetes
09/28/1999US5958403 Localized immunosuppression by insertion of nucleic acid sequence encoding cytotoxic t-cell lymphocyte antigen-immunoglobulin operably linked to promoter into an islet cell, ex vivo
09/28/1999US5958402 Antitumor therapy using ovine or bovine interferon-tau
09/28/1999US5958401 Method of using IL-11 for treating psoriasis
09/28/1999US5958400 Isolated polypeptide comprising specified amino acid sequence
09/28/1999US5958384 Use of emu oil for stimulating skin and hair growth
09/28/1999US5958378 High dose liposomal aerosol formulations containing cyclosporin A or budesonide
09/28/1999CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts
09/28/1999CA2076678C Improved chimeric toxins
09/27/1999CA2227425A1 Cell-based gene therapy
09/26/1999CA2264260A1 Polynucleotide molecules encoding neospora proteins
09/24/1999CA2249660A1 Novel compounds
09/23/1999WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis
09/23/1999WO1999047708A1 Antisense modulation of pecam-1
09/23/1999WO1999047707A1 Antisense modulation of lfa-3
09/23/1999WO1999047697A1 Novel molecules of the g protein-coupled heptahelical receptor superfamily and uses therefor
09/23/1999WO1999047680A1 Mutant recombinant allergens
09/23/1999WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/23/1999WO1999047677A2 Polypeptides homologous to vegf and bmp1
09/23/1999WO1999047676A1 Human leupaxin polypeptide and dna encoding it, their uses
09/23/1999WO1999047675A1 Mu-1, member of the cytokine receptor family
09/23/1999WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer
09/23/1999WO1999047673A2 Isolated mammalian membrane protein genes and related reagents
09/23/1999WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
09/23/1999WO1999047670A1 Mammalian sodium channel proteins
09/23/1999WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors
09/23/1999WO1999047668A2 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances
09/23/1999WO1999047666A1 Human ci-mnll homolog gene: cbfbmd04